Here, journalists can find comprehensive information, the latest news, and in-depth insights into the work of the Grünhorn Group and the medical cannabis market. Whether you're seeking an interview with our leading experts, planning a company visit, or have specific press inquiries, we are at your service and committed to supporting your reporting needs—reliably and in line with your deadlines.
Since the introduction of medical cannabis in 2017 and its removal from the Narcotics Act in April 2024, the Grünhorn Group has established itself as one of the central points of contact for healthcare professionals and patients in Germany. With our wholesale operations and the country's largest cannabis pharmacy, we have been a driving force in the industry since 2020. Our expert network possesses extensive knowledge, which we are eager to share with you to enrich the public discourse on medical cannabis.
Maja Hoock
Head of Corporate Communications
Schurer Pharma & Kosmetik GmbH / Grünhorn
Permoser Straße 19
04318 Leipzig
presse@gruenhorn.de
0341-4430494
Please note that our communications team can only respond to press inquiries. For all patient inquiries or other matters, please use the contact form or support@gruenhorn.de!
In den Presseverteiler
aufnehmen lassen
MEDIA
CENTER
KNOWN FROM:
LATEST PRESS RELEASES
6 Monate Cannabis-Legalisierung: Erstes Fazit
Von Stefan Fritsch, CEO der Grünhorn Gruppe Als ich 2020 Grünhorn gründete, war mir bewusst,…
"There are no regulations to further advance the cannabis industry in Saxony!"
At a time when the legalization of cannabis in Germany is opening new opportunities...
SOMAÍ Launches Mint-Flavored Cannabis Extracts with Grünhorn
SOMAÍ Pharmaceuticals launches its innovative mint-flavored cannabis extracts on the German market for the first time and cooperates with...
Grünhorn CEO on G-BA decision on cannabis as a statutory health insurance benefit
"Less waiting time for patients - more trust in doctors" The Federal Joint Committee (G-BA) today...